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Abstract From a Xenopus stage 11 cDNA library, we have 
cloned a gene, termed X-filAR, whose sequence is highly 
homologous to that of the human Pi-adrenergic receptor. As 
shown by RT-PCR assay, X-filAR RNA is present in the mature 
oocyte, decreases after fertilization up to stage 6 and then 
gradually increases during gastrulation. Binding studies per-
formed with radiolabeled ligands reveal that X-fllAR RNA is 
translated into the receptor protein. Furthermore, noradrenaline 
and adrenaline are also detected in oocytes and early embryos. 
The concomitant presence of Pi-adrenergic receptors and 
catecholamines suggest that this ligand-receptor couple could 
play a role in the very early stages of embryonic development. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Early embryogenesis is associated with key development 
events, such as determination of various cell lineages and 
specification of body axes. The generation of diversity and 
pattern are interdependent in animal development and con-
tribute to the patterning of the whole embryo. 
Before fertilization, the Xenopus oocyte already comprises 
the prospective ectoderm in the pigmented animal pole and 
the prospective endoderm in the yolky vegetal pole. The third 
embryonic layer, mesoderm, is generated during the segmen-
tation following fertilization and proceeds through the emis-
sion of an inductive signal from the endoderm to the overlying 
ectoderm [1]. Mesoderm induction can begin as early as the 
32-cell stage [2] and mesodermal cells are already patterned 
along the dorso-ventral axis. Indeed, the specification map of 
early mesoderm shows a localized region of dorsal character, 
fated to form notochord and head mesoderm, and an ex-
tended ring, of ventral character, fated to form muscle, lateral 
plate mesoderm and blood [3]. 
These patterning and inductive events are accomplished 
through cell interactions which involve the emission and the 
decoding of various signals. Over the past years, diffusible 
signals have been shown to be expressed during early embryo-
genesis and to display biological activity with regard to the 
patterning and induction of mesoderm. 
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The active molecules in mesoderm induction are peptide 
growth factors belonging to two families, the TGF-P family 
with activins [4,5], bone morphogenetic protein 4 (BMP-4) [6] 
and Vgl [7], and the FGF family [8,9]. The inducing proper-
ties of these two families of molecules are not identical, as the 
FGF isoforms only induce ventrolateral mesoderm [10] where-
as activins and Vgl can induce all types of mesoderm [7,11]. 
Interestingly, activins display a concentration-dependent ac-
tivity with respect to the induction of mesoderm subtypes 
[12], suggesting that a gradient of this molecule along the 
dorso-ventral axis could be the molecular basis for mesoderm 
patterning. 
The receptors which bind the ligands belonging to the 
FGFs [13,14] or to the TGF-p family [15,16] were later dem-
onstrated to be expressed during early embryogenesis. All 
these receptors belong to the class of receptor enzymes which 
contain a kinase activity on the same polypeptide chain as the 
ligand-binding site. 
We wished to ascertain whether other classes of receptors 
involved in signal transduction were likely to participate in 
early embryogenesis. As transcripts encoding the a and P 
subunits of GTG-binding proteins are expressed at early em-
bryonic stages [17-20], we looked for the concomitant expres-
sion of G protein-coupled receptors. Using primers located in 
consensus sequences of transmembrane segments of G pro-
tein-coupled receptors as described [21], we amplified two ma-
jor cDNA fragments in a reaction mixture containing reverse-
transcribed mRNA purified from Xenopus gastrulas. The 
smallest amplified fragment allowed us to isolate a full-length 
cDNA which encodes a new G protein-coupled receptor, X-
msr, whose expression is associated with an endothelial line-
age [22]. 
We report here on the characterization of the largest am-
plified fragment, the cloning of the corresponding cDNA and 
its expression during early embryogenesis. 
2. Materials and methods 
2.1. Embryos 
Fertilized embryos were obtained as previously described [23]. Stag-
ing was established according to the tables of Nieuwkoop and Faber 
[24]. 
2.2. RNA extraction 
Total RNA was extracted from 10 staged Xenopus embryos by the 
addition of 900 ul RNA-B (Bioprobe). Phenol extraction was per-
formed after addition of 100 ul chloroform. RNA was isolated by 
isopropanol precipitation of the aqueous layer and then dissolved in 
DEPC-treated water. 
2.3. PCR amplification of G protein-coupled receptor sequences 
In an effort to clone Xenopus serpentine receptor genes by PCR 
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amplification, we used degenerate oligonucleotides located in sequen-
ces of transmembrane domains III and VI, as defined [21]: primer Ill-
s', 5'-AAAGGATCCCTGTG(C/T)G(C/T)(G/C)AT(C/T)GCNNT(G/ 
T)GA(C/T)(C/A)G(C/G)T AC-3'; primer VI-3', 5'-AAGAATTCA(T/ 
G)G(A/T)AG(A/T)AGGGCAGCCAGCAGAN(G/C)(G/A)(T/C)GA-
A-3'. cDNA was synthesized in a 20 (xl reaction mixture containing 5 
ug of total RNA isolated from staged 10 embryos using the Super-
Script II Gibco BRL kit. 1 ul cDNA was used as a template in a 50 ul 
amplification mixture containing 200 uM dNTPs, 2.5 U Taq DNA 
polymerase (Boehringer Mannheim) and 0.5 uM of each primer. Dur-
ing the 35 cycles of the reaction, the denaturing, annealing and ex-
tension steps were optimized for 1 min at 94°C, 55°C, 72°C, respec-
tively. The 500 bp amplified fragment was purified by the GeneClean 
procedure (Bio-101) and subcloned in a pIBI vector. The insert was 
sequenced using a Sequenase II kit (USB). 
2.4. Cloning of the full-length serpentine receptor cDNA 
The Xenopus laevis cDNA library was made at developmental stage 
11 in Xgt 10 by Krieg and Melton [25]. This library was plated on 
Escherichia coli C600/hfla~ at a density of 20000-30000 plaques per 
140 mm plate. Recombinants were transferred to nitrocellulose filters 
(Hybond C, Amersham), denatured, baked for 2 h in vacuo at 80°C 
and prehybridized in 50% formamide, 5XSSC, 2xDenhardt's solu-
tion, 0.1% SDS at 42°C for 3 h. Hybridization was carried out for 16 
h at 42°C, in the same buffer containing 50 ug/ml sonicated salmon 
sperm DNA with, as probe, 2X106 cpm per filter of the 500 bp 
amplified cDNA fragment corresponding to the coding region be-
tween the third and the sixth transmembrane segments, randomly 
labeled with [32P]oc-dCTP (Amersham). The filters were washed in 
buffers of decreasing stringency down to 0.1XSSC, 0.1% SDS at 
42°C and autoradiographed overnight. Positive clones were purified 
and subjected to secondary and tertiary screening. The selected clones 
were digested with EcoRl and subcloned in pIBI31 vector. The insert 
was then sequenced with a Sequenase II kit (USB). 
The 5' region was isolated by a PCR-based strategy using the 5' 
RACE method. Amplification of the 5' coding region was performed 
using standard procedures of the 5' RACE-amplifinder kit (Clon-
tech): RNA from stage 10 embryos was reverse-transcribed with a 
specific PI primer corresponding to nucleotides 729-752. The PCR 
amplification was then carried out with a primer containing an anchor 
and a specific P2 primer corresponding to nucleotides 275-294. An 
amplified 599 bp fragment was identified and found to overlap the 
nucleotide sequence of the inserts. The sequence given in Fig. 1 is the 
cumulative full-length cDNA resulting from the assembly of the over-
lapping regions obtained from the 5' RACE-amplified fragment and 
the largest insert which includes most of the coding sequence (175-
1155) and the 3' untranslated region. 
2.5. RT-PCR analysis of X-§1AR mRNA levels 
The RNA extraction and reverse transcription were performed from 
10 oocytes or staged embryos as described above. 4 ul cDNA was 
used as a template in a 50 ul amplification mixture containing 200 uM 
dNTPs, 2.5 U Taq DNA polymerase (Boehringer Mannheim) and 0.2 
uM of each primer. The X-filAR amplified fragment was obtained 
with a 5' primer (274-292) and a 3' primer (1257-1233) during 40 
cycles of denaturing, annealing and extension steps optimized for 
1 min at 94°C, 60°C, 72°C, respectively. The X-Gpl amplified 
fragment was obtained with a 5' primer (183-204) and a 3' primer 
(1021-1001) during 30 cycles of denaturing, annealing and extension 
steps optimized for 1 min at 94°C, 55°C, 72°C, respectively. 10 ul of 
PCR reaction was loaded on a 1% TAE agarose gel. After migration 
of the samples, the gel was dried at 70°C for 30 min, denatured for 20 
min in 0.5 M NaOH/0.15 M NaCl and neutralized for 20 min in 0.5 
M Tris pH 8/0.15 M NaCl. The same purified amplified fragments 
were randomly labeled with [32P]a-dCTP and used as probes for hy-
bridization. 
2.6. Preparation of oocyte and embryo membranes 
One hundred oocytes or staged embryos were homogenized in 1.5 
ml homogenization buffer (25 mM HEPES, pH 7.8, 150 mM NaCl, 
2 mM EDTA, 1 mM PMSF, 30 ug/ml aprotinin) The homogenates 
were centrifuged at lOOOOXg for 5 min. The clear supernatants were 
then centrifuged at 47000Xg for 30 min and the final pellet resus-
pended in 500 ul of binding buffer (50 mM Tris-HCl, pH 7.5, 0.5 mM 
MgCl2, 1 mM EDTA, 1 mM PMSF, 30 ug/ml aprotinin). 
2.7. Binding studies with radioligands 
30 ul of membranes was incubated in the presence of 10 ul effector 
and 10 ul radioligand. The incubation in the presence of 5 nM 
[3H]CGP 20714A (46 Ci/mmoi) was performed at room temperature 
for 30 min whereas that in the presence of 150 pM [125I]CYP (2000 Ci/ 
mmol) was carried out at 30°C for 90 min. The reaction was stopped 
by adding 3 ml of cold 50 mM Tris-HCl, pH 8 and filtered on What-
man GF/C filters. The filters were washed four times with 3 ml of the 
same buffer and then dried before counting. 
2.8. Catecholamine dosage 
Ten oocytes or staged embryos were homogenized in 300 ul 0.1 N 
HCIO4 containing 1 mM EDTA and 4 mM sodium metabisulfite. 
After centrifugation at 12000Xg for 10 min at 4°C, the clear super-
natant was further purified by classical absorption on alumina and 
with dihydroxybenzylamine as internal standard. Levels of noradrena-
line and adrenaline were measured with high pressure liquid chroma-
tography (HPLC) with electrochemical detection. The HPLC equip-
ment consisted of a Model P1500 pump (Spectra system LC) and AS 
3500 autosampler (Thermo Separation Products) and Coulochem II 
electrochemical detector 5200A (ESA Inc.). The analysis was made on 
a Hypersil ODS C18 column (5 um, 150X4.6 mm i.d., Shandon 
HPLC) maintained at 31°C. The mobile phase was 0.27 mM citric 
acid hydrate, 50 mM anhydrous sodium acetate, 0.83 mM octanesul-
fonic acid, 1.07 mM EDTA and 8%. methanol adjusted to pH 4.3. The 
flow rate of the solvent was 1 ml/min. 
3. Results 
3.1. Cloning of X-jilAR cDNA 
During the search for serpentine receptors expressed during 
early embryogenesis of Xenopus, we cloned a c D N A encoding 
the amphibian homologue of a (3-adrenergic receptor. The 
cloning was performed by P C R technology in which primers 
corresponding to t ransmembrane domains III and VI were 
used to amplified total Xenopus stage 10 cDNA, as described 
[21]. Two major P C R products, a 500 bp and a 432 bp 
fragment, were obtained and subcloned into the pIBI vector. 
The characterization of the 432 bp fragment and its related 
full-length c D N A has been published elsewhere [22]. D N A 
sequencing of the larger P C R product revealed that its de-
duced protein sequence contained two hydrophobic domains 
corresponding to potential t ransmembrane segments IV and V 
and several invariant residues of this receptor superfamily 
[26]. 
Four partial full-length c D N A clones were first isolated 
from a Xenopus stage 11 c D N A library [25] using the cloned 
500 bp P C R fragment as a hybridization probe. Unfortu-
nately, the largest insert recovered from these positive colonies 
appeared to lack 174 nucleotides in the 5' coding region. We 
decided therefore to use the R A C E methodology in order to 
obtain the full-length c D N A . 
The overlapping sequences of R A C E products and partial 
full-length c D N A provides an open reading frame (1155 bp) 
which encodes a protein of 385 amino acids with a predicted 
molecular mass of 45 k D a (Fig. 1). A n A T G codon at residue 
+1 is in the context proposed for an initiation codon [27]. The 
hydropathicity plot of the amino acid sequence of X - p l A R 
reveals the presence of seven hydrophobic regions correspond-
ing to the putative t ransmembrane domains. Furthermore, the 
protein sequence contains the invariant residues found in most 
serpentine receptors, regardless of their ligand, such as an 
aspartate residue in the second transmembrane domain, the 
D R Y sequence at the end of the third t ransmembrane domain 
and a t ryptophan residue in the middle of the fourth and sixth 
t ransmembrane segments [26]. 
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-300 ACC ACC AAC GTG GCA CCT GCA GCT GAG GGA CTA GAA AAC TCC ATA GCC CAG AGG AGT CAC 
-2 4 0 TGG CAG CCA CAA CTG TAC TGA AAG TGT AGC AGC TCA CAA GCC CCC GGC TTA TTC ATC CAG 
-18 0 GAG ACA GAG AGA CTG GCA CAG TCC AGC CCA GTG GCA CGA GAG TCT GCA CCA ACC AGG GGG 
-120 AGT TAT AGT TTC TGG ACA CAA GAG ACT ACC TGG CAT CCC GCT GGC ACC GAC ACT TTC TTT 
-60 CTG TTC TGA TAT TCT GTT GCC CAA ATG ATC TGA GGC TCC AGG CTA GGA CCT ATG CCC ATC 
ATG GGA GAC GGT TGG GGG CCT ATG GAG TGC AGG AAC AGG TCT GGT ACC CCT ACA ACA GTG 
M G D G W G P M E C R N R S G T P T T V 
CCC AGC CCT ATG CAC CCC CTG CCC GAG CTC ACT CAC CAG TGG ACT ATG GGA ATG ACT ATG 
P S P M H P L P E L T H Q W T M G M T M 
TTC ATG GCG GCC ATC ATC CTC CTC ATC GTC ATG GGC AAC ATC ATG GTC ATT GTG GCC ATT 
F M A A I I L L I V M G N I M V I V A I 
GGG AGG AAC CAG AGG CTC CAG ACC TTG ACC AAC GTC TTC ATC ACG TCC TTG GCT TGT GCC 
G R N Q R L Q T L T N V F I T S L A C A 
GAC CTC ATT ATG GGT TTG TTT GTT GTG CCC CTT GGT GCC ACG TTG GTG GTG AGT GGC AGG 
D L I M G L F V V P L G A T L V V S G R 
TGG CTG TAC GGG TCG ATA TTC TGT GAG TTC TGG ACG TCA GTG GAC GTA TTG TGC GTC ACG 
W L Y G S I F C E F W T S V D V L C V T 
GCG AGT ATA GAG ACC CTG TGC GTC ATC TCC ATC GAC CGC TAC ATC GCC ATC ACC TCA CCC 
A S I E T L C V I S I D R Y I A I T S P 
TTC CGC TAC CAG AGT CTC CTG ACC AAG GGC CGT. GCC AAG GGA ATC GTG TGC AGC GTG TGG 
F R Y Q S L L T K G R A K G I V C S V W 
GGC ATC TCA GCC CTG GTC TCG TTC CTG CCC ATC ATG ATG CAC TGG TGG AGG GAC ACT GGC 
G I S A L V S F L P I M M H W W R D T G 
GAC CCC CTG GCC ATG AAA TGT TAC GAG GAT CCT GGG TGC TGT GAT TTT GTC ACC AAC AGA 
D P L A M K C Y E D P G C C D F V T N R 
GCT TAC GCC ATC GCC TCG TCC ATC ATC TCC TTC TAT TTC CCA CTC ATC ATC ATG ATC TTC 
A Y A I A S S I I S F Y F P L I I M I F 
GTC TAC ATC AGG GTC TTC AAG GAG GCG CAG AAG CAG ATG AAG AAG ATT GAC AAG TGC GAG 
V Y I R V F K E A Q K Q M K K I D K C E 
GGC AGG TTC TCC CAT AGC CAC GTC CTG AGC CAC GGC AGG TCC AGC CGG AGG ATC CTC TCC 
G R F S H S H V L S H G R S S R R I L S 
AAA ATC CTG GTG GCC AAA GAG CAG AAA GCC TTG AAG ACC CTC GGG ATT ATC ATG GGC ACC 
K I L V A K E Q K A L K T L G I I M G T 
TTC ACC CTG TGC TGG TTG CCC TTC TTC TTG GCC AAC GTG GTC AAT GTC TTC TAC AGG AAC 
F T L C W L P F F L A N V V N V F Y R N 
CTG ATC CCA GAC AAA CTC TTC CTC TTC CTC AAC TGG CTG GGC TAC GCC AAC TCC GCG TTT 
L I P D K L F L F L N W L G Y A N S A F 
AAC CCC ATC ATC TAC TGC AGG AGC CCA GAC TTC AGG AAG GCT TTC AAG AGA CTC CTG TGT 
N P I I Y C R S P D F R K A F K R L L C 
TGC CCC AAA AAG GCA GAT CGG CAC CTC CAC ACT ACT GGG GAG CTC TCC CGA TAC TCG GGG 
C P K K A D R H L H T T G E L S R Y S G 
GGC TTT GTT AAC TCT TTA GAC ACC AAT GCT TTG GGT ATG TGT TCT GAA TGT AAT GGG GTG 
G F V N S L D T N A L G M C S E C N G V 
CGG ACG TCA TTG GAC TGA AAT TAA TTA TTT ATT GTG GGT CGG AGG GAG ATT GAA TAA GTG 
R T S L D * 
GGT GCG GGG CCC CAA ATA ACA GGT AGG TTC CAG GCA ACC TCA CTG CAG ATT CTT GGA ATG 
TAG AGG GTT CCC CAG GAT AGG AGT 
Fig. 1. Nucleotide and deduced amino acid sequence of the open reading frame of X-$1AR cDNA. The positions of the starting methionine 
and stop codon are designated by M and * respectively. Numbers refer to the cDNA sequence (+1 corresponding to the ATG codon) and the 
derived amino acid sequence. 
3.2. Sequence analysis of X-/51AR protein (Fig. 2). The percentages of identical amino acids in the se-
EMBL and GenBank database searches revealed that the quence of X-J31AR compared to those of the human pVadre-
whole amino acid sequence displays significant homology to nergic receptor [28], the human |32-adrenergic receptor [29] 
those of the different subtypes of [3-adrenergic receptors and the human pVadrenergic receptor [30] are 66%, 55% 
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X-BlAR 
h-BlAR 
h-B2AR 
h-B3AR 
X-PlAR 3 8 
h-BlAR 6 1 
h-B2AR 3 6 
h-P3AR 
X-BlAR 9 7 gsgjjJELl 
h-BlAR 12 0 WWSHHE 
h-p2AR 9 5 gMKMgJTB 
h-B3AR 9 9 StfgHjSPL 
X-81AR 1 5 7 
h-piAR 18 0 
h-P2AR 1 5 5 h 
h-p3AR 1 5 9 VL| 
X-plAH 2 1 7 
h-piAR 2 3 9 
h-p2AR 2 1 4 
h-p3AR 2 1 9 
X-piAR 2 4 7 H P W S H E 
h-piAR 2 9 9 APmANS 
h-(32AR 2 4 7 Q5SEQDS 
h-fS3AR 2 7 0 Eg 
X-PlAR 
h-PlAR 
h-P2AR 
fOPiJECRNRSOTPfair 
/•LVgGASEPGNLS||(A| 
MHraLPg FJTH5T 
DQAATAARLLVPASPPASLti 'PgASgSPEpQsQ^ 
QPGNGSAFLLAPNRSHA----BDHDVTQQRDE\ 
QWHHENSS LAPWPDLPTLAPNTANTSGLPGVP[J]EAA 
ILLIVWGNMJiVlVAIMlWWRLQTLTNVFITSLACADI.MMGI.aVVPUGATLV 
lSSR--gjILg3l[3v. 
JAGK- -BRPSRX-VAL 
3TGHGLgRSa2P-CI,[33H| 
rPACG-gRPARLESPL' 
PPEESPPAPSRSLAPAPVGTCAPP-
KEp,KALKTLGIIMGTFTLCWLPFFLANV\ 
3EQKALKTLGiIMGBJFTLCWLPFFLANV\ 
X-piAR 3 04 
h-piAR 3 5 6 
h-p2AR 3 0 5 KEV^CllI 
h-P3AR 3 2 5 GP 
DWLFLFI.NWLGYANSAFNPIT.YCRSPDFRKAFMRLI.ee 
FLMLNWLGYANSAFNPtfllYCRSPDFR 
-LRRSS0KAJ3GNE 
-|tCG[ijR[3PPEP 
X-plAR 3 6 3 V N S L D Q N l | L g M C - - g g 
h-piAR 416 ARPGPPPSPEAA--BDDDDDDWGATPPARLLEPWAGI 
h-p2AR 3 5 5 SSNGS0GEO.SGYHVEQEKENKLLCEDLPGT--EDFVGHQ[j 
h-p3AR 3 7 2 ' CAAARPALFPS--
G A A A D S D | S E E P C R P G F A S 
TVPSDNID0QGRNCS TN 
PAARSSPAQPRLCQR-LDG 
4 74 ESKV 
4 1 0 DSLL 
h-P3AR 4 0 3 
Fig. 2. Sequence analysis of the X-(31AR protein. The predicted amino acid sequence of X-piAR was compared with that of the three subtypes 
of p-adrenergic receptors cloned from human species. Global alignment of the sequences of amphibian X-plAR receptor, human Pi-adrenergic 
receptor [28], human p2-adrenergic receptor [29] and human p3-adrenergic receptor [30] was made with the Clustal V program. Identical resi-
dues are indicated by black boxes. 
and 46%, respectively. Consequently, the higher degree of 
homology observed between the amphibian sequence and 
the human Pi-adrenergic receptor [28] strongly suggests that 
we have cloned the amphibian homologue of the Pi-adrener-
gic receptor. 
3.3. Expression of X-/51AR mRNA in Xenopus oocytes and 
embryos 
Expression of the X-$1AR gene was undetectable by North-
ern blot analysis. The low abundance levels of X-filAR tran-
scripts led us to use a RT-PCR assay for studying the tempo-
ral expression of X-filAR mRNA during early embryogenesis. 
As shown in Fig. 3, the level of X-filAR mRNA changes 
significantly during early development. An amplified fragment 
of the expected size (984 bp) was present in the oocyte. How-
ever, the amount of amplified fragments decreases signifi-
cantly up to stage 6. From stage 8, mRNA levels gradually 
increase to reach high levels at larval stages. The constancy of 
amounts and loading of reverse-transcribed cDNAs was 
judged by PCR amplification with primers located in the se-
quence of the Pi subunit of heterotrimeric GTP-binding pro-
teins (Fig. 3) whose expression does not vary in the early 
stages of development [20]. These results clearly indicate 
that X-$1AR mRNA represents a maternal RNA whose levels 
gradually decline after fertilization up to stage 6. At the mid-
blastula transition, the activation of the zygotic genome might 
Fig. 3. Kinetics of X-$1AR gene expression. The upper part of the figure corresponds to amplification of the X-$1AR cDNA with primers cor-
responding to nucleotides 584-603 and 1540-1565. The lower part of the figure corresponds to amplification of the X-Gfil cDNA with primers 
located at positions 183-206 and 1002-1021. Total RNAs were isolated from unfertilized eggs (ovo) or staged embryos and reverse-transcribed 
as described in Section 2. Amplified fragments were loaded on a 1% agarose gel. The dried gel was probed with the same amplified fragments 
which were randomly labeled with [32P]a-dCTP. The expected size of each amplified fragment is indicated. 
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Ci/mmol) did not facilitate the accurate determination of such 
a low number of binding sites, we used an indirect approach 
involving the displacement of a saturating concentration of 
[125I]CYP, a 'universal' P antagonist, in the presence of unla-
beled CGP 20714A. To better examine the temporal varia-
tions, we narrowed the time interval between the different 
developmental stages that we analyzed before and after gas-
trulation. As shown in Fig. 4B, the numbers of binding sites in 
the oocytes and stage 10 embryos are very similar to those 
determined by the direct binding of the Pi agonist. In addi-
tion, they decrease in stage 6 embryos, reaching the lowest 
levels of stage 10 embryos, to increase again in the early larval 
stage (stages 22-24). 
Consistent with the RNA result, the level of X-|31AR pro-
tein is high in the oocyte and begins to decrease gradually 
upon fertilization. However, compared to the RNA, X-
plAR protein decreases at a slower rate and is still detectable 
at stage 6. This does not necessarily reflect a higher sensitivity 
of binding studies compared to PCR amplification, but rather 
suggests that the X-piAR protein is more stable than the 
mRNA and remains present after the disappearance of the 
latter. 
It should be pointed out that the binding assay not only 
measures the amount of protein but also examines its func-
tion, at least at the level of extracellular signal recognition. 
Fig. 4. Measurement of X-piAR binding sites. A: Direct measure-
ment by [3H]CGP 20714A. Membranes were prepared from oocytes 
and staged embryos as described in Section 2. Membranes were in-
cubated with 5 nM [3H]CGP 20714A in the absence (total binding) 
or presence of 1 |xM propranolol (non-specific binding). The specific 
binding corresponds to the propranolol-displaced binding. The val-
ues represent the mean of triplicate determinations from a represen-
tative experiment. B: Indirect measurement by the CGP 20714A-in-
duced displacement of [125I]cyanopindolol binding. Membranes were 
incubated with 150 pM [125I]cyanopindolol in the absence (total 
binding) or presence of 1 |xM CGP 20714A (non-specific binding). 
The specific binding corresponds to the binding displaced by CGP 
20714A. The values represent the mean of triplicate determinations 
from a representative experiment. 
be responsible for the increased mRNA levels observed after 
stage 8. 
3.4. Expression of X-J51AR protein in Xenopus oocytes and 
embryos 
In order to determine whether the protein and mRNA lev-
els are correlated during early development, we first measured 
the number of binding sites at a saturating concentration of 
[3H]CGP 20714A, a specific agonist of Pi-adrenergic recep-
tors. Because of the large numbers of oocytes and embryos 
required for preparing the membranes used in binding studies, 
we first chose three representative developmental stages: the 
mature oocyte, the gastrula stage and a late larval stage. As 
shown in Fig. 4A, the oocyte contains an intermediate number 
of binding sites, whereas the gastrula displays a very low 
number of sites; on the other hand, the late larva possesses 
a large number of Pi-adrenergic receptors. 
Because the low specific activity of the tritiated ligand (46 
'3 
o u 
E 
"O""- adrenaline 
" ^ noradrenaiinc 
OVO 2 4 6 8 10 12 14 24 
Embryonic stages 
Fig. 5. Catecholamine content of oocytes and embryos. Ten oocytes 
or staged embryos were homogenized and their catecholamine levels 
determined using HPLC analysis as described in Section 2. Noradre-
naline and adrenaline amounts are given in nmol/mg protein. Values 
represent the determination from pooled embryos and were obtained 
in a representative experiment. 
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3.5. Detection of nor adrenaline in Xenopus oocytes and 
embryos 
At all the stages that were assayed, noradrenaline and adre-
naline were detected (Fig. 5). Significant levels of noradrena-
line and adrenaline were also observed in the oocyte. The 
highest levels were found at stage 4 for adrenaline and at stage 
6 for noradrenaline. The lowest amounts were observed at 
gastrulation, between stages 10 and 12. Subsequently, levels 
of both catecholamines increased again during early larval 
stages. 
4. Discussion 
We have shown the presence of mRNA encoding Pi-adren-
ergic receptors, characterized the existence of Pi-adrenergic 
binding sites and detected their putative ligands in early Xe-
nopus embryos. 
As far as Pi-adrenergic receptors are concerned, we have 
demonstrated the presence of maternal mRNAs before the 
mid-blastula transition which are relayed by the synthesis of 
zygotic mRNAs whose amount increases during neurulation. 
Similarly, pi-adrenergic binding sites were also characterized 
but the decrease of the maternal protein as well as the increase 
of the zygotic protein were delayed when compared to those 
of the mRNA. Such a temporal difference could be explained 
by a differential turn-over of each species or a translational 
regulation. Interestingly, targeted disruption of the mouse Px-
adrenergic receptor gene is associated with a significant pre-
natal lethality and impaired cardiac performance [31]. As 
death occurs in late embryos, these data reveal that the Pi-
adrenergic receptors required at a late stage of mouse develop-
ment correspond to the zygotic receptors expressed in Xenopus 
embryos. On the other hand, these results do not address the 
question of the role played by the maternal pi-adrenergic 
receptors. 
Whatever the function of maternal receptors may be, it is 
noteworthy that we were able to detect the concomitant pres-
ence of catecholamines in oocytes and early embryos. Not 
only did we detect significant amounts of dopamine (data 
not shown), like Rowe et al. [32], but also low levels of nor-
adrenaline and adrenaline, before the early neurula stage. The 
early detection of these catecholamines is doubtless explained 
by the high sensitivity of the electrochemical sensor. Interest-
ingly, the decrease of catecholamine content between stages 6 
and 10 strongly parallels that of the number of Pi-adrenergic 
binding sites. Although the presence of catecholamines in oo-
cytes does not imply their de novo synthesis, the observed 
increase at stages 4 and 6 tends to suggest the existence of 
the enzyme machinery for such synthesis. Indeed, targeted 
disruption of mouse tyrosine hydroxylase [33] and dopamine 
P-hydroxylase [34] genes results in gestational lethality, with 
the same histological phenotype, due to cardiovascular failure. 
Again, these data correspond to the phase of catecholamine 
synthesis starting after the mid-blastula transition and cannot 
reveal the function of maternal catecholamines. 
Since we started this work, recent reports have largely con-
firmed the validity of the general hypothesis that G protein-
coupled receptors are expressed early in development and play 
a role in embryonic cell interactions. Several papers describe 
the characterization of putative G protein-coupled receptors 
for two signaling molecules implicated in numerous patterning 
events during development: Dfz2, a candidate wingless recep-
tor [35], and Smo, a candidate hedgehog receptor [36,37]. A 
new G protein-coupled receptor is expressed in endothelial 
precursor during cardiogenesis and vasculogenesis [22]. Fi-
nally, serotonin receptors displaying the pharmacological 
properties of the mammalian 5-HT2 subtype are highly ex-
pressed during early Drosophila embryogenesis [38]. 
Interestingly, like the catecholamines, serotonin is mostly 
known for its neurotransmitter function in the mature central 
nervous system. Thus, besides the characterization of seroto-
nin-like receptors, the concomitant presence of serotonin and 
of its complete machinery of synthesis strongly emphasizes a 
new role for serotonin signaling and transduction pathways in 
the decoding of early developmental signals in Drosophila [38]. 
In this context, the concomitant detection of noradrenaline 
and adrenaline as well as the expression of Pi-adrenergic re-
ceptors in Xenopus embryos tend to suggest that such an early 
developmental role for biogenic amines is not restricted to 
serotonin and that catecholamine signaling pathways might 
exert novel developmental functions in addition to their 
known role in differentiated cells of adult tissues. 
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